A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis
Status:
Completed
Trial end date:
2019-04-04
Target enrollment:
Participant gender:
Summary
This is a double-blind, pilot study with 20 subjects to determine the tolerability and
efficacy of topical AFX 5931 in the treatment of mild to moderate hand dermatitis. Subjects
are screened up to 30 days before the baseline visit. Subjects who meet the eligibility
criteria may qualify for the study. Subjects will be randomized in a 3:1 ratio to receive
either the active or vehicle medication. 15 subjects will receive the active, therapeutic
product and 5 subjects will receive the inactive, vehicle product.